DESCRIPTION (provided by applicant): The presence of alpha-synuclein (alpha-SYN) aggregate in Lewy neurites (LNs) and Lewy bodies (LBs), the pathological hallmarks of Parkinson's disease (PD), and mitochondrial dysfunction are two central components in PD pathogenesis. Known physiological roles of alpha-SYN are limited in synaptic terminals, raising the possibility that alpha-SYN mRNA is transported to neurites and its translation is locally controlled. In fact, we have recently found that alpha-SYN mRNA is translocated into neurites of fully differentiated human dopaminergic neuronal cells. We also identified that Pum2, a paralogue of mammalian PUF family RNA binding protein, binds to a PUM binding motif of the alpha-SYN 3'UTR and is responsible for neuritic localization as well as translational repression of alpha-SYN mRNA. Mitochondrial ROS generated by respiratory complex I inhibition led to local translation of alpha-SYN from mRNA associated with mitochondria, suggesting that Pum2 might transmit mitochondrial signal to alpha-SYN translation. Although it is obvious that there is an inter- relationship between mitochondria and alpha-SYN underlying the development of disease, molecular mechanisms governing this cross-talk remain elusive. Our central hypothesis is that Pum2 is responsible for alpha-SYN mRNA transport to the juxta-mitochondrial compartment, alpha-SYN translational regulation and aggregation in neurites. The objectives of this project are to understand the interplay between alpha-SYN and mitochondria in neurites through Pum2-mediated translational regulation of mitochondria-associated alpha-SYN mRNA. To achieve these objectives we propose the following three specific aims: Aim 1. Examine the role of Pum2 in mitochondrial localization of alpha-SYN mRNA. Aim 2. Examine how mitochondrial ROS control alpha-SYN translation. Aim 3. Determine how newly synthesized alpha-SYN near mitochondria affects mitochondrial fragmentation and alpha-SYN aggregation in neurites. The successful completion of the project will bring a paradigm shift in our understanding of molecular mechanisms that control alpha-SYN level in neurites and how mitochondrial ROS contribute to this alpha-SYN regulation. The results expected from the project will open new avenues to understand 1) 3'UTR-dependent posttranscriptional regulation of alpha-SYN in neurites and Pum2's role in this process, 2) intimate crosstalk between alpha-SYN and mitochondria in neurites and 3) its contribution to mitochondrial fragmentation and LN formation.
|Effective start/end date||7/1/14 → 6/30/16|
- National Institute of Neurological Disorders and Stroke: $180,977.00
- Molecular Biology
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.